Highest-materiality recent filing
P&G Q3 net sales +7% to $21.2B, core EPS $1.59; guides toward lower end of FY range
Net sales $21.2B (+7%), organic sales +3% driven by 2% volume growth and 1% pricing.
P&G Q3 FY2026 organic sales +3%, core EPS $1.59, guidance maintained
Organic sales +3% (volume +2%, price +1%); 10 of 10 categories and 7 of 7 regions grew.
P&G declares quarterly dividend increase to $1.0885, up 3%
Quarterly dividend raised to $1.0885 per share, a 3% increase vs prior quarter.
P&G Q2 FY2026: Net sales +1% to $22.2B, core EPS flat at $1.88, maintains FY guidance
Diluted EPS $1.78 (-5% YoY); core EPS $1.88 (flat); organic sales unchanged.
P&G Q2 FY26: organic sales flat, core EPS $1.88, guidance maintained
Q2 organic sales +0% (volume -1%, pricing +1%); core EPS $1.88, in-line with prior year.
P&G declares regular quarterly dividend of $1.0568 per share
Dividend of $1.0568 per share payable on or after Feb 17, 2026 to holders of record Jan 23, 2026.
P&G Health Care CEO Jennifer Davis to retire June 30, 2026
Jennifer Davis, CEO - Health Care, notified P&G on Dec 9, 2025 of retirement effective June 30, 2026.
Procter & Gamble closes $258.9M floating-rate notes offering due 2075
Issued $258,889,000 aggregate principal of Floating Rate Notes due Nov 4, 2075.
P&G closes €1B and $1.25B multi-tranche note offerings
Issued €500M of 2.900% notes due 2033 and €500M of 3.650% notes due 2045.
P&G Q1 FY2026: net sales $22.4B (+3%), diluted EPS $1.95 (+21%), core EPS $1.99 (+3%)
Organic sales +2%; volume neutral, pricing +1%, mix +1%. Beauty organic sales +6%, Grooming +3%.
P&G Q1 FY2026: organic sales +2%, core EPS $1.99 (+3% YoY); reaffirms guidance
Q1 organic sales +2% (flat volume, +1% pricing, +1% mix); core EPS $1.99 (+3% YoY); adjusted free cash flow 102%.
Procter & Gamble shareholders approve 2025 Stock Plan authorizing 175M shares
Shareholders approved The Procter & Gamble 2025 Stock and Incentive Compensation Plan, authorizing up to 175,000,000 shares of common stock.
P&G declares quarterly dividend of $1.0568; all 14 director nominees elected
Quarterly dividend of $1.0568 per share on common and Series A/B preferred stock, payable November 17, 2025 to holders of record October 24, 2025.
P&G Beauty CEO Alexandra Keith to retire on Feb 20, 2026 after 36 years
Alexandra Keith, CEO of Beauty at P&G, announced retirement effective February 20, 2026.
P&G reports Q4 FY2025 net sales +2% to $20.9B, diluted EPS +17% to $1.48; FY2025 EPS $6.51 +8%
FY2025 net sales $84.3B (flat YoY), organic sales +2%; diluted EPS $6.51 (+8%), core EPS $6.83 (+4%).
P&G Q4 FY2025 organic sales +2%, core EPS +6%; FY2026 guidance core EPS growth 0-4%
FY2025 organic sales +2% (vol +1%, price +1%); core EPS $6.83 (+4% YoY); adj. free cash flow productivity 87%.
Shailesh Jejurikar, age 58, currently COO, will succeed Jon Moeller as President and CEO effective January 1, 2026.
P&G declares quarterly dividend of $1.0568 per share, payable August 15, 2025
Quarterly dividend of $1.0568 per share on common stock and Series A/B ESOP preferred stock.
P&G appoints former Eaton CEO Craig Arnold to Board of Directors
Craig Arnold, former Chairman and CEO of Eaton Corporation, elected to P&G board effective June 9, 2025.
P&G announces 2-year restructuring; to cut up to 7,000 roles, record $1.0-1.6B charge
Program includes portfolio choices (brand exits in certain markets), supply chain optimization, and organization design.
On June 9, 2025, the Board of Directors of The Procter & Gamble Company (the “Company”) appointed Craig Arnold, former Chairman and Chief Executive Officer of Eaton Corporation, as a Director of the Company, effective June 9.
Max materiality 0.90 · Median 0.60 · Most common event earnings